Position in RPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,300,944
+$45,299 QoQ
Shares Held
41,037
-12.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#258
of 641 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 59%
Shared 41%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACQUARIE GROUP LTD holds $47,158,112 across 21 Biotechnology names. RPRX ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
37,980 | $18,865,804 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,532 | $10,931,901 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
20,943 | $6,304,471 | |
| 4 | INCY |
Incyte Corp
|
33,301 | $3,775,000 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
41,037 | $2,300,944 | |
| 6 | EXEL |
Exelixis, Inc.
|
27,485 | $1,495,458 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,331 | $623,829 | |
| 8 | INSM |
INSMED Inc
|
5,193 | $553,677 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,300,944 | 41,037 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,255,645 | 47,022 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,779,182 | 71,925 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,878,589 | 53,248 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,492,159 | 69,169 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,153,230 | 69,169 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $1,177,235 | 46,148 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,323,632 | 46,788 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,233,799 | 46,788 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,388,698 | 45,726 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,284,443 | 45,726 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $990,854 | 36,509 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $559,621 | 18,205 | Shares | Sole | 2023-10-27 | |
| 2023-03-31 | $332,304 | 9,223 | Shares | Sole | 2023-06-01 | |
| 2022-12-31 | $364,492 | 9,223 | Shares | Defined | 2023-02-21 | |
| 2022-09-30 | $284,393 | 7,078 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $194,686 | 4,631 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $180,423 | 4,631 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $107,634 | 2,701 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $183,627 | 5,081 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $208,269 | 5,081 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $215,657 | 4,944 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $100,100 | 2,000 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||